News | May 1, 2019
Crown Laboratories, Inc. acquired the North American rights for Keri from GlaxoSmithKline (GSK). The acquisition of Keri from GSK marks the sixth product from GSK that Crown has acquired in the past five months. “Acquiring...
News | April 29, 2019
Excess weight is a contributing factor for developing psoriasis, and the greater the body mass index (BMI), the higher the chance of getting the disease, according to a new study. To investigate the causal relationship between BMI and...
News | May 16, 2019
Extracorporeal shockwaves (ESWT) initiated within the operation field prior to surgery may improve wound healing and minimize scar formation, according to a pilot study in Lasers in Surgery and Medicine (LSM). The study was selected...
News | April 28, 2019
Xstrahl Medical is launching its latest superficial radiotherapy treatment system to treat the full range of non-melanoma skin cancer cases. The new Xstrahl 150 system offers several features that enhance the capabilities of...
News | April 16, 2019
Linda Esposito is the new Chief Financial Officer at Skyn ICELAND, a privately held New York-based skin care company. Ms. Esposito will report to Founder and Chief Executive Officer Sarah Kugelman and will oversee all financial...
Acquisitions and Mergers
Business of Medicine
Earnings and Financials
Phase 3/4 Trials
Product Launches and Updates
Research and Publications
Skin of Color
Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIA
ISDIN Teams Up with The Claire Marie Foundation And The Ulman Foundation For Skin Cancer Awareness Month
Obagi Launches SKINCLUSION Initiative to Celebrate Diversity with Brand Ambassador Priyanka Chopra Jonas
Abeona Therapeutics to Present EB-101 Data at Society for Investigative Dermatology Annual Meeting